VIR - CIK 0001706431
The table below shows Vir Biotechnology, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $274.16M | $170.08M | $211.10M | $273.57M | $168.35M | $296.86M |
| Short-term investments | $196.28M | $327.75M | $387.64M | $517.37M | $740.61M | $849.83M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $522.99M |
| $545.68M |
| $735.71M |
| $932.21M |
| $1.05B |
| $1.21B |
| Property, plant & equipment | $53.16M | $58.20M | $60.80M | $61.68M | $64.79M | $66.06M |
| Goodwill | $16.94M | $16.94M | $16.94M | $16.94M | $16.94M | $16.94M |
| Total assets | $1.03B | $1.02B | $1.19B | $1.31B | $1.50B | $1.67B |
| Accounts payable | $5.45M | $6.85M | $12.23M | $3.73M | $7.30M | $4.39M |
| Total current liabilities | $73.56M | $75.22M | $105.00M | $137.29M | $117.16M | $96.41M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $212.82M | $223.35M | $245.06M | $263.91M | $257.63M | $235.88M |
| Retained earnings | -$1.32B | -$1.15B | -$991.71M | -$880.75M | -$655.20M | -$441.48M |
| Total equity | $812.76M | $796.10M | $947.47M | $1.04B | - | - |